• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑源性神经营养因子和三构象维持蛋白样试剂挽救亨廷顿病小鼠模型皮质突触缺陷。

BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.

机构信息

Department of Neurology, The Fourth Hospital of Harbin Medical University, 150001, China; Department of Neurosciences, University of California San Diego, La Jolla, CA 92093, United States of America.

Department of Neurosciences, University of California San Diego, La Jolla, CA 92093, United States of America.

出版信息

Neurobiol Dis. 2024 Jun 1;195:106502. doi: 10.1016/j.nbd.2024.106502. Epub 2024 Apr 10.

DOI:10.1016/j.nbd.2024.106502
PMID:38608784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11890210/
Abstract

Synaptic changes are early manifestations of neuronal dysfunction in Huntington's disease (HD). However, the mechanisms by which mutant HTT protein impacts synaptogenesis and function are not well understood. Herein we explored HD pathogenesis in the BACHD mouse model by examining synaptogenesis and function in long term primary cortical cultures. At DIV14 (days in vitro), BACHD cortical neurons showed no difference from WT neurons in synaptogenesis as revealed by colocalization of a pre-synaptic (Synapsin I) and a post-synaptic (PSD95) marker. From DIV21 to DIV35, BACHD neurons showed progressively reduced colocalization of Synapsin I and PSD95 relative to WT neurons. The deficits were effectively rescued by treatment of BACHD neurons with BDNF. The recombinant apical domain of CCT1 (ApiCCT1) yielded a partial rescuing effect. BACHD neurons also showed culture age-related significant functional deficits as revealed by multielectrode arrays (MEAs). These deficits were prevented by BDNF, whereas ApiCCT1 showed a less potent effect. These findings are evidence that deficits in BACHD synapse and function can be replicated in vitro and that BDNF or a TRiC-inspired reagent can potentially be protective against these changes in BACHD neurons. Our findings support the use of cellular models to further explicate HD pathogenesis and potential treatments.

摘要

突触变化是亨廷顿病(HD)神经元功能障碍的早期表现。然而,突变 HTT 蛋白影响突触发生和功能的机制尚不清楚。在此,我们通过检查长期原代皮质培养物中的突触发生和功能,探讨了 BACHD 小鼠模型中的 HD 发病机制。在 DIV14(体外天数),与 WT 神经元相比,BACHD 皮质神经元在突触发生方面没有差异,这是通过前突触(Synapsin I)和后突触(PSD95)标记物的共定位来揭示的。从 DIV21 到 DIV35,与 WT 神经元相比,BACHD 神经元的 Synapsin I 和 PSD95 共定位逐渐减少。BDNF 处理有效挽救了 BACHD 神经元的缺陷。重组 CCT1 的顶端结构域(ApiCCT1)产生部分挽救效果。BACHD 神经元还表现出与培养年龄相关的显著功能缺陷,如多电极阵列(MEA)所示。BDNF 可预防这些缺陷,而 ApiCCT1 的效果较弱。这些发现证明了 BACHD 突触和功能的缺陷可以在体外复制,BDNF 或受 TRiC 启发的试剂可能对 BACHD 神经元的这些变化具有保护作用。我们的研究结果支持使用细胞模型进一步阐明 HD 的发病机制和潜在的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/3b18fc6db14f/nihms-2057913-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/ac1a6c4210be/nihms-2057913-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/474b055d5705/nihms-2057913-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/ca2c48bdc268/nihms-2057913-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/973f9e1d52d0/nihms-2057913-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/3198d4dd7634/nihms-2057913-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/f8ee4ae72c23/nihms-2057913-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/e21a72d54dab/nihms-2057913-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/1e612cc72012/nihms-2057913-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/3b18fc6db14f/nihms-2057913-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/ac1a6c4210be/nihms-2057913-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/474b055d5705/nihms-2057913-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/ca2c48bdc268/nihms-2057913-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/973f9e1d52d0/nihms-2057913-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/3198d4dd7634/nihms-2057913-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/f8ee4ae72c23/nihms-2057913-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/e21a72d54dab/nihms-2057913-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/1e612cc72012/nihms-2057913-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7160/11890210/3b18fc6db14f/nihms-2057913-f0009.jpg

相似文献

1
BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.脑源性神经营养因子和三构象维持蛋白样试剂挽救亨廷顿病小鼠模型皮质突触缺陷。
Neurobiol Dis. 2024 Jun 1;195:106502. doi: 10.1016/j.nbd.2024.106502. Epub 2024 Apr 10.
2
TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.TRiC亚基增强脑源性神经营养因子的轴突运输并挽救亨廷顿舞蹈病中的纹状体萎缩。
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5655-64. doi: 10.1073/pnas.1603020113. Epub 2016 Sep 6.
3
Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease.亨廷顿病 BACHDΔN17 小鼠模型中中间棘神经元的结构和功能特征。
PLoS One. 2020 Jun 23;15(6):e0234394. doi: 10.1371/journal.pone.0234394. eCollection 2020.
4
Increased Activity-Dependent Bulk Endocytosis in Huntington's Disease Results From Huntingtin Haploinsufficiency.亨廷顿病中活性依赖性巨胞饮增加源于亨廷顿蛋白单倍体不足。
J Neurochem. 2025 Jun;169(6):e70134. doi: 10.1111/jnc.70134.
5
Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation.尽管亨廷顿舞蹈病Q175DN小鼠模型中HTT聚集增加,但海马病理改变仍未出现。
J Huntingtons Dis. 2025 Feb;14(1):59-84. doi: 10.1177/18796397251316762. Epub 2025 Feb 3.
6
Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.罗克洛文,一种 CDK 抑制剂,通过靶向 HTT 在 S1181 和 S1201 上的磷酸化,减少了 mHTT 的神经元毒性。
Int J Mol Sci. 2024 Nov 16;25(22):12315. doi: 10.3390/ijms252212315.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Intrastriatal Delivery of a Zinc Finger Protein Targeting the Mutant HTT Gene Allele Obviates Lipid Phenotypes in Brain and Plasma in Huntington's Disease Mice.向纹状体内递送靶向突变型亨廷顿蛋白(HTT)基因等位基因的锌指蛋白可消除亨廷顿病小鼠大脑和血浆中的脂质表型。
Hum Gene Ther. 2025 Aug;36(15-16):1083-1094. doi: 10.1177/10430342251359955. Epub 2025 Jul 23.
9
Mechanisms of synapse-to-nucleus calcium signalling in striatal neurons and impairments in Huntington's disease.纹状体神经元突触核钙信号转导的机制及其在亨廷顿病中的作用障碍。
J Neurochem. 2024 Sep;168(9):2671-2689. doi: 10.1111/jnc.16132. Epub 2024 May 21.
10
Complex cognitive and motivational deficits precede motor dysfunction in the zQ175 (190 CAG repeat) Huntington's disease model.在zQ175(190个CAG重复序列)亨廷顿舞蹈症模型中,复杂的认知和动机缺陷先于运动功能障碍出现。
Exp Neurol. 2025 Jun 23;392:115350. doi: 10.1016/j.expneurol.2025.115350.

引用本文的文献

1
Brain-derived neurotrophic factor plays with TRiC: focus on synaptic dysfunction in Huntington's disease.脑源性神经营养因子与TRiC相互作用:聚焦亨廷顿舞蹈病中的突触功能障碍
Neural Regen Res. 2025 Oct 1;20(10):2919-2920. doi: 10.4103/NRR.NRR-D-24-00679. Epub 2024 Sep 24.

本文引用的文献

1
Axonal ER Ca Release Selectively Enhances Activity-Independent Glutamate Release in a Huntington Disease Model.轴突内质网 Ca2+释放选择性增强亨廷顿病模型中的活动非依赖性谷氨酸释放。
J Neurosci. 2023 May 17;43(20):3743-3763. doi: 10.1523/JNEUROSCI.1593-22.2023. Epub 2023 Mar 21.
2
BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons.BDNF/TrkB 信号内体在轴突中协调 CREB/mTOR 的激活和细胞体中的蛋白质合成,从而诱导皮质神经元的树突生长。
Elife. 2023 Feb 24;12:e77455. doi: 10.7554/eLife.77455.
3
CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons.
低温电子断层扫描揭示亨廷顿病患者 iPSC 衍生和小鼠原代神经元中的细胞器表型。
Nat Commun. 2023 Feb 8;14(1):692. doi: 10.1038/s41467-023-36096-w.
4
Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington's Disease.应激与内质网-线粒体相互作用在亨廷顿病中的作用
Int J Mol Sci. 2022 Jan 11;23(2):780. doi: 10.3390/ijms23020780.
5
Innovative Therapeutic Approaches for Huntington's Disease: From Nucleic Acids to GPCR-Targeting Small Molecules.亨廷顿舞蹈症的创新治疗方法:从核酸到靶向GPCR的小分子
Front Cell Neurosci. 2021 Nov 26;15:785703. doi: 10.3389/fncel.2021.785703. eCollection 2021.
6
Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway.亨廷顿病中的突触病理学:超越皮质纹状体通路。
Neurobiol Dis. 2022 Jan;162:105574. doi: 10.1016/j.nbd.2021.105574. Epub 2021 Nov 27.
7
Huntingtin and the Synapse.亨廷顿蛋白与突触
Front Cell Neurosci. 2021 Jun 15;15:689332. doi: 10.3389/fncel.2021.689332. eCollection 2021.
8
Editorial: Synaptic Loss and Neurodegeneration.社论:突触丧失与神经退行性变
Front Cell Neurosci. 2021 Apr 21;15:681029. doi: 10.3389/fncel.2021.681029. eCollection 2021.
9
Huntington's Disease: New Frontiers in Therapeutics.亨廷顿病:治疗学的新前沿。
Curr Neurol Neurosci Rep. 2021 Feb 14;21(3):10. doi: 10.1007/s11910-021-01093-3.
10
Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.亨廷顿病中的突触功能障碍:遗传动物模型的启示。
Neuroscientist. 2022 Feb;28(1):20-40. doi: 10.1177/1073858420972662. Epub 2020 Nov 16.